On Prednisone which she tapered from 15 to 10 mg daily on Monday.
Baseline sats in low 90s on 5L with drops to 70s-80s with minimal exertion.
In [**2116-4-14**], a follow-up CT torso revealed progression of R cavitary lesion, new L pulmonary nodule and increased in mediastinal LAD.
CT torso [**11-21**] revealed progressive lung nodules and increased LAD.
Scans in [**5-23**] showed progression of disease with CEA trending up.
Pertinent Results: [**2119-2-9**] 10:44AM BLOOD WBC-12.4* RBC-3.38* Hgb-9.4* Hct-29.3* MCV-87 MCH-27.7 MCHC-32.0 RDW-14.3 Plt Ct-314 [**2119-2-10**] 04:31AM BLOOD WBC-9.3 RBC-3.15* Hgb-8.9* Hct-27.2* MCV-86 MCH-28.1 MCHC-32.6 RDW-13.7 Plt Ct-236 [**2119-2-11**] 05:08AM BLOOD WBC-12.6* RBC-3.16* Hgb-8.8* Hct-27.1* MCV-86 MCH-27.8 MCHC-32.4 RDW-13.9 Plt Ct-300 [**2119-2-9**] 10:44AM BLOOD Neuts-88.4* Lymphs-6.4* Monos-3.5 Eos-1.5 Baso-0.2 [**2119-2-9**] 10:44AM BLOOD PT-12.0 PTT-24.2 INR(PT)-1.0 [**2119-2-9**] 10:44AM BLOOD Glucose-152* UreaN-14 Creat-0.7 Na-134 K-4.0 Cl-93* HCO3-29 AnGap-16 [**2119-2-10**] 04:31AM BLOOD Glucose-156* UreaN-18 Creat-0.6 Na-132* K-5.1 Cl-92* HCO3-32 AnGap-13 [**2119-2-10**] 01:47PM BLOOD Glucose-158* UreaN-25* Creat-0.7 Na-130* K-4.5 Cl-89* HCO3-31 AnGap-15 [**2119-2-11**] 05:08AM BLOOD Glucose-115* UreaN-27* Creat-0.9 Na-134 K-4.3 Cl-94* HCO3-35* AnGap-9 [**2119-2-9**] 10:44AM BLOOD ALT-9 AST-12 LD(LDH)-301* AlkPhos-166* TotBili-0.4 [**2119-2-9**] 10:44AM BLOOD proBNP-371* [**2119-2-9**] 10:44AM BLOOD Albumin-3.3* Calcium-9.1 Phos-3.1 Mg-1.5* [**2119-2-11**] 05:08AM BLOOD Calcium-9.5 Phos-3.7 Mg-2.1 [**2119-2-9**] 01:21PM BLOOD Type-ART pO2-68* pCO2-48* pH-7.46* calTCO2-35* Base XS-8 [**2119-2-9**] 10:45AM BLOOD Lactate-1.5  Urine culture negative.
Blood cultures NGTD.
Urine legionella antigen negative.
CXR IMPRESSION: Overall mild increase in opactiy with more confluent opacity seen in bilateral lower lobes, may represent progression of diffuse pulmonary metastases, although infectious process can not be excluded.
Fentanyl 25 mcg/hr Patch 72 hr Sig: One (1) patch Transdermal Q72H (every 72 hours).
Followup Instructions: You have the following appointments scheduled:  Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 593**], MD Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2119-2-14**] 9:30 Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 5465**], MD Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2119-2-14**] 9:30 Provider: [**First Name4 (NamePattern1) 4617**] [**Last Name (NamePattern1) 4618**], RN Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2119-2-14**] 10:30
